Summary REPR’s flagship product has a firm grip on the growing infusion homecare market and REPR’s stock is trading at a significant discount to what it’s worth. The product is held in high regard by those in the industry, who […]
Call(s) to Action: ESYS ($12.11, up > 13% in early trading) handily beats analyst EPS estimates by 62% with EPS of $0.26 vs analyst estimates of $0.16. However, the company offers limited commentary and can experience EPS volatility quarter to […]
We published an American Heritage International (AHII) short-thesis article on Seeking Alpha yesterday, April 2, 2014. The Fraud Research Institute (Twitter, Seeking Alpha) did some due diligence of its own and discovered that AHII’s corporate status with the Nevada Secretary […]
Aegerion Pharmaceuticals (AEGR) Viability Threatened As Regulatory, Legal And Market Forces Close In
It’s not often that evidence gathered in one of our investigations into a company that is not a classic pump and dump or U.S. listed China Based company would lead the GeoTeam to conclude that the subject company’s shares could […]
GeoInvesting Presents Additional Evidence to Support Assertions In this report we will present new evidence to support our belief that AFSI’s reported financial statements are unreliable. AFSI appears to have understated gross adverse development by over $100 million, and therefore […]
After our initial report on AmTrust Capital (AFSI), “Amtrust Financial Servies: A House of Cards?“, Bronte Capital (“Bronte”) criticized the report as a “hit-piece” with “howling error after howling error”. We stand by our report and appreciate the opportunity to […]
We believe short sellers have the winning position in AmTrust Financial Services (AFSI). Owners of AFSI should take careful note of the discussions of consolidation of earnings and valuation of assets that could result in large losses and regulatory scrutiny […]
FAB Universal (FU) has completely failed to address in any substantive way a growing series of reports that challenge the core of FAB’s business and expose an almost complete lack fiduciary responsibility and corporate governance by FAB’s U.S. management: September […]